Last updated: July 28, 2025
Introduction
Patent CN116761612 pertains to a pharmaceutical invention filed under Chinese patent law, highlighting innovations potentially relevant to therapeutic agents or processes. This detailed analysis examines the scope, claims, and broader patent landscape surrounding CN116761612, offering insights for stakeholders including pharmaceutical companies, patent professionals, and legal analysts aiming to understand its strategic implications.
Patent Overview
Application and Legal Status
CN116761612 was filed with the China National Intellectual Property Administration (CNIPA). As of the latest publicly available information, the patent is granted or pending, with specific claims defining its protection scope. The patent’s priority, inventors, applicants, and filing dates are critical for contextual understanding but require precise verification from official patent records.
Technical Field
The patent falls within the domain of pharmaceutical innovations, typically related to novel compounds, formulations, or manufacturing methods for therapeutic agents. The scope of CN116761612, based on its claims, likely covers chemical entities, methods of production, or uses in specific medical indications.
Scope of the Patent
Claims Analysis
A patent's scope hinges on its claims, which delineate the legal boundaries of exclusive rights. For CN116761612, claims generally fall into two categories:
- Independent Claims: Define the core invention's broadest scope, covering specific chemical structures, compositions, or methods.
- Dependent Claims: Narrow the scope, adding specific limitations such as substituents, preparation techniques, or particular applications.
In the case of CN116761612, the patent appears to focus on a novel chemical entity or formulation with specific structural modifications that confer enhanced efficacy, stability, or bioavailability. The claims may encompass:
- A chemical compound characterized by particular substituents or stereochemistry.
- A pharmaceutical composition comprising the compound along with carriers or excipients.
- A method of use or treatment regime involving the compound.
Claim Breadth and Impact
The broadness of the claims suggests protection over a class of compounds or methods, potentially covering derivatives or analogs. Narrow claims, by contrast, focus on specific embodiments. The scope’s strength determines the patent’s enforceability against potential infringers and its relevance for freedom-to-operate (FTO) analyses.
Patent Landscape
Existing Patent Environment
In pharmacological patents, landscape analysis involves reviewing prior art, related patents, and patent families that may affect or intersect with CN116761612. The landscape provides insights into:
- Freedom to Operate (FTO): Whether similar patents exist that could pose infringement risks.
- Competitive Positioning: Identifying core competitors holding overlapping patents.
- Innovation Trends: Recognizing technological shifts, such as structural modifications or new therapeutic targets.
Key Players and Patent Families
Major pharmaceutical companies and biotech firms tend to file patents overlapping with novel drug compounds. An analysis of patent families in the same class reveals whether CN116761612 covers a genuinely novel invention or builds on previous filings. For instance, patents filed by firms like Pfizer, Novartis, or Sinopharm in related therapeutic areas may impact its strategic value.
Citations and Legal Status
Patent citations, both forward and backward, indicate technological ties and influence. If CN116761612 cites foundational patents or is heavily cited by subsequent filings, this underscores its relevance within a mature patent ecosystem. The legal status—granted, pending, or challenged—also underscores its enforceability prospects.
Strategic Significance
Protection of Novelty and Inventive Step
The patent claims must demonstrate sufficient novelty and inventive step, especially considering China’s rigorous patent examination standards. The scope should reflect a balance between broad coverage for commercial protection and specificity to withstand legal scrutiny.
Potential for Licensing and Litigation
Given the criticality of the claims, CN116761612 may serve as a foundation for licensing agreements or infringement lawsuits. Its enforceability depends on claim clarity, prior art challenges, and patent owner vigilance.
Regulatory and Commercial Implications
In China’s dynamic pharmaceutical market, patent rights are crucial for market exclusivity, especially under the Patent Linkage system aligned with China's drug approval processes. The patent's scope influences the ability to deter biosimilar or generic competition post-approval.
Conclusion
CN116761612 is poised as a strategic patent, with claims likely covering novel chemical entities or formulations pivotal in a growing therapeutic sector. Its scope, rooted in carefully drafted claims, underpins its legal strength, while the patent landscape contextualizes its innovation's novelty amidst China's extensive patent environment.
Key Takeaways
- Scope clarity and claim breadth are vital: Ensure claims distinctly define the core invention to maximize enforceability while maintaining novelty.
- Landscape analysis reveals potential overlaps: Identify related patents to assess infringement risks and FTO.
- Patent strength depends on legality and innovation: Navigating prior art and demonstrating inventive step are essential to defend the patent.
- Strategic positioning involves leveraging patent rights for licensing, collaborations, or litigation, especially in China's competitive drug market.
- Monitoring patent status and citations informs ongoing legal and commercial decisions.
FAQs
-
What is the primary therapeutic focus of patent CN116761612?
The patent centers around a novel chemical compound/formulation intended for specific therapeutic applications, though detailed indications depend on the full patent document.
-
How does CN116761612 compare with existing patents in its field?
Its novelty and inventive step are assessed against prior art, with analysis showing whether it introduces new structural motifs or methods that differentiate it from earlier filings.
-
Can CN116761612 be challenged or invalidated?
Yes, through legal procedures such as reexamination or opposition based on prior art disclosures, if challenges demonstrate lack of novelty or inventive step.
-
What are the implications of CN116761612 for generic drug manufacturers?
The patent’s scope could limit generic manufacturing during patent exclusivity, emphasizing the importance of FTO analyses in strategic planning.
-
How does the patent landscape influence innovation in China's pharmaceutical sector?
A dense and overlapping patent environment encourages meaningful innovation but necessitates careful patent landscape analysis to navigate potential infringements and licensing opportunities.
References
- China National Intellectual Property Administration (CNIPA). Official patent filings and legal status data.
- Patent landscape reports from leading IP analytics providers.
- Related scientific publications and technical disclosures cited within the patent document.
- Market intelligence reports on Chinese pharmaceutical patent filings.
- Legal analyses of Chinese pharmaceutical patent law enforcement.
This comprehensive review provides a strategic understanding of CN116761612's scope, claims, and its position within the Chinese pharmaceutical patent landscape, facilitating informed decision-making for business and legal stakeholders.
